161 related articles for article (PubMed ID: 36963292)
21. Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.
Gulati R; Feuer EJ; Etzioni R
Am J Epidemiol; 2016 Jul; 184(2):140-7. PubMed ID: 27358266
[TBL] [Abstract][Full Text] [Related]
22. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening.
Moss S
Breast Cancer Res; 2005; 7(5):230-4. PubMed ID: 16168145
[TBL] [Abstract][Full Text] [Related]
23. Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update.
Bennett A; Beck A; Shaver N; Grad R; LeBlanc A; Limburg H; Gray C; Abou-Setta A; Klarenbach S; Persaud N; Thériault G; Thombs BD; Todd KJ; Bell N; Dahm P; Loblaw A; Del Giudice L; Yao X; Skidmore B; Rolland-Harris E; Brouwers M; Little J; Moher D
Syst Rev; 2022 Oct; 11(1):230. PubMed ID: 36289518
[TBL] [Abstract][Full Text] [Related]
24. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
25. The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening
Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
[TBL] [Abstract][Full Text] [Related]
26. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
Ebell MH; Bentivegna M; Hulme C
Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
[TBL] [Abstract][Full Text] [Related]
27. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
Jung M
Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
[TBL] [Abstract][Full Text] [Related]
28. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?
Chaltiel D; Hill C
BMJ Open; 2021 Jun; 11(6):e046353. PubMed ID: 34158298
[TBL] [Abstract][Full Text] [Related]
29. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
Draisma G; Etzioni R; Tsodikov A; Mariotto A; Wever E; Gulati R; Feuer E; de Koning H
J Natl Cancer Inst; 2009 Mar; 101(6):374-83. PubMed ID: 19276453
[TBL] [Abstract][Full Text] [Related]
30. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
31. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
32. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
33. The other side of technology: risk of overdiagnosis of breast cancer with mammography screening.
Puliti D; Paci E
Future Oncol; 2009 May; 5(4):481-91. PubMed ID: 19450177
[TBL] [Abstract][Full Text] [Related]
34. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
35. Missteps in Current Estimates of Cancer Overdiagnosis.
Lee CI; Etzioni R
Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
[TBL] [Abstract][Full Text] [Related]
36. Screening for prostate cancer.
Ilic D; O'Connor D; Green S; Wilt T
Cochrane Database Syst Rev; 2006 Jul; (3):CD004720. PubMed ID: 16856057
[TBL] [Abstract][Full Text] [Related]
37. Prognostic selection and long-term survival analysis to assess overdiagnosis risk in lung cancer screening randomized trials.
Paci E; Puliti D; Carozzi FM; Carrozzi L; Falaschi F; Pegna AL; Mascalchi M; Picozzi G; Pistelli F; Zappa M;
J Med Screen; 2021 Mar; 28(1):39-47. PubMed ID: 32437229
[TBL] [Abstract][Full Text] [Related]
38. Interventions for promoting habitual exercise in people living with and beyond cancer.
Bourke L; Homer KE; Thaha MA; Steed L; Rosario DJ; Robb KA; Saxton JM; Taylor SJ
Cochrane Database Syst Rev; 2013 Sep; (9):CD010192. PubMed ID: 24065550
[TBL] [Abstract][Full Text] [Related]
39. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
[TBL] [Abstract][Full Text] [Related]
40. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]